Narlin Beaty
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Narlin Beaty has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- Madison M. Patrick
Department of Neurosurgery, University of Alabama at Birmingham, Birmingham, AL 35294, USA
3 shared publications - Luke Hudson
Department of Clinical Sciences, Florida State University College of Medicine, Tallahassee, FL 32306, USA
2 shared publications Alexander L Coon
Department of Neurosurgery, Carondelet Neurological Institute, Carondelet Saint Joseph’s Hospital, Tucson, Arizona, USA
1 shared publication- Alexander L. Coon
Carondelet Neurosurgical Institute of St. Joseph's Hospital, Tucson, Arizona, USA
1 shared publication - Benjamen M. Meyer
College of Medicine, University of Arizona, Tucson, AZ, USA
1 shared publication - Brenda Hranec
Department of Clinical Sciences, Florida State University College of Medicine, Tallahassee, FL 32306, USA
1 shared publication
Latest Publications
- Open Access
- 24 September 2026
- Published by MDPI AG in Journal of Vascular Diseases
- Vol. 5 (5) , 38
Artificial Intelligence in Neurovascular Surgery: Emerging Applications in Intracranial Aneurysm Management
Background/Objectives: Artificial intelligence (AI) has emerged as a promising adjunct in intracranial aneurysm (IA) care, with potential applications in diagnosis, rupture risk assessment, treatment planning, and outcome prediction. This review summarizes current AI-based approaches in the management and prognostication of IAs. Methods: A structured search of PubMed, Embase, and Scopus was conducted for English-language studies published from January 2001 to 14 April 2026, evaluating machine learning (ML), deep learning, or large language model (LLM) applications in IA diagnosis, treatment, or prognosis. After screening and full-text review, 45 studies were included. Results: AI models demonstrated utility across several domains of aneurysm care. Deep learning approaches supported aneurysm detection and morphological segmentation, while traditional ML models were applied to rupture status classification, aneurysm stability, treatment selection, occlusion prediction, and post-treatment outcomes. Emerging LLMs showed early promise in treatment recommendation and prognostication, although evidence remains limited. Conclusions: AI may improve individualized aneurysm management from initial diagnosis to long-term outcome prediction by integrating clinical, radiographic, procedural, and hemodynamic data beyond conventional scoring systems. However, current models are limited by retrospective designs, heterogeneous outcomes, limited external validation, and concerns regarding interpretability, bias, and clinical implementation. Prospective multicenter validation and standardized reporting are needed before AI tools can be reliably incorporated into routine aneurysm care.
- 24 September 2026
- Published by MDPI AG in Journal of Vascular Diseases
- Vol. 5 (5) , 38
Open AccessArtificial Intelligence in Neurovascular Surgery: Emerging Applications in Intracranial Aneurysm Management
Background/Objectives: Artificial intelligence (AI) has emerged as a promising adjunct in intracranial aneurysm (IA) care, with potential applications in diagnosis, rupture risk assessment, treatment planning, and outcome prediction. This review summarizes current AI-based approaches in the management and prognostication of IAs. Methods: A structured search of PubMed, Embase, and Scopus was conducted for English-language studies published from January 2001 to 14 April 2026, evaluating machine learning (ML), deep learning, or large language model (LLM) applications in IA diagnosis, treatment, or prognosis. After screening and full-text review, 45 studies were included. Results: AI models demonstrated utility across several domains of aneurysm care. Deep learning approaches supported aneurysm detection and morphological segmentation, while traditional ML models were applied to rupture status classification, aneurysm stability, treatment selection, occlusion prediction, and post-treatment outcomes. Emerging LLMs showed early promise in treatment recommendation and prognostication, although evidence remains limited. Conclusions: AI may improve individualized aneurysm management from initial diagnosis to long-term outcome prediction by integrating clinical, radiographic, procedural, and hemodynamic data beyond conventional scoring systems. However, current models are limited by retrospective designs, heterogeneous outcomes, limited external validation, and concerns regarding interpretability, bias, and clinical implementation. Prospective multicenter validation and standardized reporting are needed before AI tools can be reliably incorporated into routine aneurysm care.
- Open Access
- 9 March 2026
- Published by MDPI AG in Journal of Vascular Diseases
- Vol. 5 (2) , 13
Structural Weakness: Collagen Alterations in Cerebral Aneurysm Development
Background/Objectives: Aneurysms develop secondary to progressive weakening of arterial walls and remain a major cause of morbidity and mortality worldwide. Collagen, particularly fibrillar types I and III, is the primary tensile load-bearing component of arteries, yet its specific role in aneurysm formation, progression, and rupture is incompletely defined. This narrative review synthesizes current evidence on collagen structure, regulation, and degradation in aneurysm pathophysiology, highlighting cerebral aneurysms within the broader context of aneurysms as a whole. Methods: Searches of PubMed, MEDLINE, Embase, and Google Scholar were performed to identify all English-language studies published prior to January 2026. Search terms included “cerebral aneurysm”, “collagen”, “extracellular matrix”, “vascular remodeling”, and “aneurysm rupture”. Included studies evaluated collagen structure or content, extracellular matrix remodeling, matrix metalloproteinases, or biomechanical properties of the aneurysm wall in experimental or human models. Results: The literature search identified 348 records, of which 87 studies published between 1999 and 2025 met the inclusion criteria and were synthesized in this review. Collagen types I and III form the primary tensile scaffold of intracranial arteries, while basement membrane and regulatory collagens (e.g., types IV, V, and VI) modulate fibril organization, endothelial stability, and mechanical homeostasis. Research demonstrates that endothelial dysfunction, nitric oxide dysregulation, oxidative stress, and matrix metalloproteinase activation are key pathways driving collagen fragmentation and degradation. Genetic and epigenetic disturbances in collagen and related extracellular matrix pathways further increase aneurysm susceptibility. Conclusions: Collagen dysregulation appears to be a final common pathway through which hemodynamic, inflammatory, hormonal, and genetic insults converge to weaken intracranial arterial walls. However, existing evidence is dominated by animal and aortic models, and in vivo tools, such as Magnetic Resonance Imaging with collagen-sensitive sequences and Positron Emission Tomography Tracers, to quantify collagen integrity in cerebral aneurysms are lacking. Future efforts should prioritize human-focused studies, advanced collagen-sensitive imaging, biomarker development, and targeted strategies to preserve or restore collagen structure as potential means to improve aneurysm risk stratification, prevention, and treatment.
- 9 March 2026
- Published by MDPI AG in Journal of Vascular Diseases
- Vol. 5 (2) , 13
Open AccessStructural Weakness: Collagen Alterations in Cerebral Aneurysm Development
Background/Objectives: Aneurysms develop secondary to progressive weakening of arterial walls and remain a major cause of morbidity and mortality worldwide. Collagen, particularly fibrillar types I and III, is the primary tensile load-bearing component of arteries, yet its specific role in aneurysm formation, progression, and rupture is incompletely defined. This narrative review synthesizes current evidence on collagen structure, regulation, and degradation in aneurysm pathophysiology, highlighting cerebral aneurysms within the broader context of aneurysms as a whole. Methods: Searches of PubMed, MEDLINE, Embase, and Google Scholar were performed to identify all English-language studies published prior to January 2026. Search terms included “cerebral aneurysm”, “collagen”, “extracellular matrix”, “vascular remodeling”, and “aneurysm rupture”. Included studies evaluated collagen structure or content, extracellular matrix remodeling, matrix metalloproteinases, or biomechanical properties of the aneurysm wall in experimental or human models. Results: The literature search identified 348 records, of which 87 studies published between 1999 and 2025 met the inclusion criteria and were synthesized in this review. Collagen types I and III form the primary tensile scaffold of intracranial arteries, while basement membrane and regulatory collagens (e.g., types IV, V, and VI) modulate fibril organization, endothelial stability, and mechanical homeostasis. Research demonstrates that endothelial dysfunction, nitric oxide dysregulation, oxidative stress, and matrix metalloproteinase activation are key pathways driving collagen fragmentation and degradation. Genetic and epigenetic disturbances in collagen and related extracellular matrix pathways further increase aneurysm susceptibility. Conclusions: Collagen dysregulation appears to be a final common pathway through which hemodynamic, inflammatory, hormonal, and genetic insults converge to weaken intracranial arterial walls. However, existing evidence is dominated by animal and aortic models, and in vivo tools, such as Magnetic Resonance Imaging with collagen-sensitive sequences and Positron Emission Tomography Tracers, to quantify collagen integrity in cerebral aneurysms are lacking. Future efforts should prioritize human-focused studies, advanced collagen-sensitive imaging, biomarker development, and targeted strategies to preserve or restore collagen structure as potential means to improve aneurysm risk stratification, prevention, and treatment.
- 23 March 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (2) , 576-584
Computational flow dynamics of a novel next-generation flow diverter
Background Flow-diverting stents (FDS) have revolutionized the treatment of large, giant, and wide-neck intracranial aneurysms. FDS promote thrombosis and aneurysm occlusion by redirecting blood flow within the parent artery. This method of endovascular therapy has proven efficacious, although leaving room for improvement. This study evaluated computational flow dynamics (CFD) and technical feasibility of the novel Surpass Elite FDS (Elite) in comparison with the Pipeline Embolization Device with Shield Technology (PED-Shield) across seven in vitro aneurysm models. Methods Surpass Elite FDS and PED-Shield were assessed primarily with three CFD metrics to quantify flow diversion: inflow rate reduction, impact zone reduction, and turnover time. Seven patient-specific aneurysm models were utilized. These included one basilar tip, one vertebral artery, two middle cerebral artery, and three internal carotid artery aneurysms. Further evaluation of pore densities and velocity profiles was performed to create a robust comparison summary. Results Surpass Elite FDS demonstrated greater reduction in inflow rate and impact zone with improved turnover time in all models. Elite additionally displayed higher pore densities at nearly all proximal (inlet), aneurysm, and distal (outlet) points across the aneurysm models. Conclusions The next-generation Surpass Elite established better CFD metrics in comparison with PED-Shield in all in vitro aneurysm models evaluated here. Further, Elite demonstrated a higher pore density at nearly all aneurysm points assessed in this study, promoting enhanced flow diversion and thrombosis in the aneurysm sac. Considering these findings, Elite has strong potential to improve on the occlusion rates of PED-Shield.
- 23 March 2025
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 18 (2) , 576-584
Computational flow dynamics of a novel next-generation flow diverter
Background Flow-diverting stents (FDS) have revolutionized the treatment of large, giant, and wide-neck intracranial aneurysms. FDS promote thrombosis and aneurysm occlusion by redirecting blood flow within the parent artery. This method of endovascular therapy has proven efficacious, although leaving room for improvement. This study evaluated computational flow dynamics (CFD) and technical feasibility of the novel Surpass Elite FDS (Elite) in comparison with the Pipeline Embolization Device with Shield Technology (PED-Shield) across seven in vitro aneurysm models. Methods Surpass Elite FDS and PED-Shield were assessed primarily with three CFD metrics to quantify flow diversion: inflow rate reduction, impact zone reduction, and turnover time. Seven patient-specific aneurysm models were utilized. These included one basilar tip, one vertebral artery, two middle cerebral artery, and three internal carotid artery aneurysms. Further evaluation of pore densities and velocity profiles was performed to create a robust comparison summary. Results Surpass Elite FDS demonstrated greater reduction in inflow rate and impact zone with improved turnover time in all models. Elite additionally displayed higher pore densities at nearly all proximal (inlet), aneurysm, and distal (outlet) points across the aneurysm models. Conclusions The next-generation Surpass Elite established better CFD metrics in comparison with PED-Shield in all in vitro aneurysm models evaluated here. Further, Elite demonstrated a higher pore density at nearly all aneurysm points assessed in this study, promoting enhanced flow diversion and thrombosis in the aneurysm sac. Considering these findings, Elite has strong potential to improve on the occlusion rates of PED-Shield.
- Open Access
- 28 February 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (12) , 1228-1232
Use of a large-bore 088 intracranial access support catheter for delivery of large intracranial devices: case series with the TracStar LDP in 125 cases
Background The delivery of neuroendovascular devices requires a robust proximal access platform. This demand has previously been met with a 6Fr long sheath (8Fr guide) that is placed in the proximal internal carotid artery (ICA) or vertebral artery segments. We share our experience with the first 0.088 inch 8Fr guide catheter designed for direct intracranial access. Methods We retrospectively reviewed a prospectively maintained IRB-approved institutional database of the senior authors to identify all cases where the TracStar Large Distal Platform (LDP) was positioned within the intracranial vasculature, defined as within or distal to the petrous ICA, vertebral artery (V3) segments, or transverse sinus. Technical success was defined as safe placement of the TracStar LDP within or distal to the described distal vessel segments with subsequent complication-free device implantation. Results Over the 41-month study period from January 2020 to June 2023, 125 consecutive cases were identified in whom the TracStar LDP was navigated into the intracranial vasculature for triaxial delivery of large devices, 0.027 inch microcatheter and greater, for aneurysm treatment (n=108, 86%), intracranial angioplasty/stenting (n=15, 12%), and venous sinus stenting (n=2, 1.6%). All cases used a direct select catheter technique for initial guide placement (no exchange). Posterior circulation treatments occurred in 14.4% (n=18) of cases. Technical success was achieved in 100% of cases. No vessel dissections occurred in any cases. Conclusion The TracStar LDP is an 0.088 inch 8Fr guide catheter that can establish direct intracranial access with an acceptable safety profile. This can be achieved in a wide range of neurointerventional cases with a high rate of technical success.
- 28 February 2024
- Published by BMJ in Journal of NeuroInterventional Surgery
- Vol. 16 (12) , 1228-1232
Open AccessUse of a large-bore 088 intracranial access support catheter for delivery of large intracranial devices: case series with the TracStar LDP in 125 cases
Background The delivery of neuroendovascular devices requires a robust proximal access platform. This demand has previously been met with a 6Fr long sheath (8Fr guide) that is placed in the proximal internal carotid artery (ICA) or vertebral artery segments. We share our experience with the first 0.088 inch 8Fr guide catheter designed for direct intracranial access. Methods We retrospectively reviewed a prospectively maintained IRB-approved institutional database of the senior authors to identify all cases where the TracStar Large Distal Platform (LDP) was positioned within the intracranial vasculature, defined as within or distal to the petrous ICA, vertebral artery (V3) segments, or transverse sinus. Technical success was defined as safe placement of the TracStar LDP within or distal to the described distal vessel segments with subsequent complication-free device implantation. Results Over the 41-month study period from January 2020 to June 2023, 125 consecutive cases were identified in whom the TracStar LDP was navigated into the intracranial vasculature for triaxial delivery of large devices, 0.027 inch microcatheter and greater, for aneurysm treatment (n=108, 86%), intracranial angioplasty/stenting (n=15, 12%), and venous sinus stenting (n=2, 1.6%). All cases used a direct select catheter technique for initial guide placement (no exchange). Posterior circulation treatments occurred in 14.4% (n=18) of cases. Technical success was achieved in 100% of cases. No vessel dissections occurred in any cases. Conclusion The TracStar LDP is an 0.088 inch 8Fr guide catheter that can establish direct intracranial access with an acceptable safety profile. This can be achieved in a wide range of neurointerventional cases with a high rate of technical success.